Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 29581888.
- Also identified by DOI 10.1038/s41536-018-0047-2 and PMC identifier 5862830.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
In Japan, a new therapy for severe heart failure using skeletal myocardial sheet is ongoing and a treatment using iPS cells is just about to start. However, I think there are problems and concerns. In this comment, I will express concerns on these treatments. This will be useful and interesting to stem cell researchers and clinical cardiologists.